Medroxyprogesterone Acetate Clinical Trials

• Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use with Certain Anti-HIV Drugs in HIV-Infected Women
  ClinicalTrials.gov Identifier: NCT00016601 - Completed
  HIV Infections
  
• Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003179 - Active, not recruiting
  Endometrial Cancer
  
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
  ClinicalTrials.gov Identifier: NCT00064025 - Recruiting
  Endometrial Cancer
  
• Study of External Beam Radiation Therapy with and Without Hormonal Therapy to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00116220 - Active, not recruiting
  Prostate Cancer
  
• Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.
  ClinicalTrials.gov Identifier: NCT00041483 - Active, not recruiting
  Macular Degeneration
  
• An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
  ClinicalTrials.gov Identifier: NCT00058994 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related
  
• Medroxyprogesterone in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
  Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
  
• Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD
  ClinicalTrials.gov Identifier: NCT00065728 - Recruiting
  Macular Degeneration
  
• Hormonal Birth Control and the Risk of Acquiring HIV
  ClinicalTrials.gov Identifier: NCT00006324 - Completed
  HIV Infections; HIV Seronegativity
  
• Clinical Trial of Leuprolide Acetate for the Treatment of PMS
  ClinicalTrials.gov Identifier: NCT00001259 - Recruiting
  Depressive Disorder; Mood Disorder
  
• Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00416429 - Active, not recruiting
  Kidney Cancer
  
• Anecortave Acetate Risk Reduction Trial (AART)
  ClinicalTrials.gov Identifier: NCT00332657 - Active, not recruiting
  AMD
  
• Anecortave Acetate Risk-Reduction Trial (AART)
  ClinicalTrials.gov Identifier: NCT00333216 - Active, not recruiting
  AMD
  
• Alzheimer's Disease: Therapeutic Potential of Estrogen
  ClinicalTrials.gov Identifier: NCT00066157 - Active, not recruiting
  Alzheimer Disease
  
• Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00110045 - Recruiting
  Cancer; Infection
  
• Anecortave Acetate Risk-Reduction Trial (AART)
  ClinicalTrials.gov Identifier: NCT00307398 - Active, not recruiting
  Dry AMD
  
• An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD)
  ClinicalTrials.gov Identifier: NCT00051129 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related
  
• Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)
  ClinicalTrials.gov Identifier: NCT00523406 - Active, not recruiting
  Macular Degeneration
  
• Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00008359 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; Eye Cancer; kidney tumor
  
• CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00211939 - Active, not recruiting
  Calcinosis; Arteriosclerosis; Hyperparathyroidism, Secondary
  
• Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00044837 - Terminated
  HIV Infections
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
  ClinicalTrials.gov Identifier: NCT00212368 - Active, not recruiting
  Wison's Disease
  
• Study Evaluating Bazedoxifene Acetate in Osteoporosis
  ClinicalTrials.gov Identifier: NCT00205777 - Active, not recruiting
  Osteoporosis
  
• Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
  ClinicalTrials.gov Identifier: NCT00030914 - Completed
  Hot Flashes
  
• A Comparison of Three Different Formulations of Prednisolone Acetate 1%
  ClinicalTrials.gov Identifier: NCT00345046 - Recruiting
  Glaucoma; Cataract
  
• Efficacy and Safety,Long-Term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
  ClinicalTrials.gov Identifier: NCT00212355 - Active, not recruiting
  Wilson's Disease
  
• Luteal Phase FSH in the IVF Poor Reponder
  ClinicalTrials.gov Identifier: NCT00225433 - Active, not recruiting
  Infertility
  
• Dose-Range-Finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
  ClinicalTrials.gov Identifier: NCT00402337 - Active, not recruiting
  Chronic Constipation
  
• A Phase II Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Failed Taxane-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00474383 - Active, not recruiting
  Prostate Cancer
  
• Anecortave Acetate in Patients With Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00299507 - Active, not recruiting
  Macular Degeneration
  
• Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00211419 - Active, not recruiting
  Maculopathy, Age-Related
  
• Study of Abiraterone Acetate in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00473512 - Active, not recruiting
  Hormon Refractory Prostate Cancer
  
• The Effect of Lapaquistat Acetate on Blood Cholesterol Levels When Given With Statins
  ClinicalTrials.gov Identifier: NCT00532311 - Recruiting
  Hypercholesterolemia
  
• Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer
  ClinicalTrials.gov Identifier: NCT00081094 - Active, not recruiting
  adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
  
• Treatment of Age-Related Macular Degeneration With Anecortave Acetate
  ClinicalTrials.gov Identifier: NCT00211458 - Active, not recruiting
  Macular Degeneration
  
• The Effects of Continuous Administration of a Monophasic Oral Contraceptive (Norethindrone Acetate/Ethinyl Estradiol 1/20ug) on Bleeding Days and Endometrial and Ovarian Function
  ClinicalTrials.gov Identifier: NCT00128726 - Active, not recruiting
  menstrual cycle
  
• Prophylactic Anecortave Acetate in Patients With a Retisert Implant
  ClinicalTrials.gov Identifier: NCT00570479 - Recruiting
  Uveitis, Posterior; Glaucoma
  
• Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
  ClinicalTrials.gov Identifier: NCT00315640 - Recruiting
  Eye Diseases
  
• Clinical Trial for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
  Prostate Cancer
  
• Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
  ClinicalTrials.gov Identifier: NCT00211354 - Active, not recruiting
  Retinal Vein Occlusion
  
• Hormonal Contraception and Risk of Chlamydia and Gonorrhea
  ClinicalTrials.gov Identifier: NCT00091728 - Terminated
  Chlamydia Infection; Neisseriaceae Infection
  
• BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
  ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
  Multiple Sclerosis
  
• Positron Emission Tomography Using Carbon-11 Acetate in Finding Metastasis and Predicting Recurrence in Patients with Newly Diagnosed Prostate Cancer Who Are At Risk for Recurrence After Treatment
  ClinicalTrials.gov Identifier: NCT00121212 - Recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
  ClinicalTrials.gov Identifier: NCT00337779 - Active, not recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
  ClinicalTrials.gov Identifier: NCT00372697 - Recruiting
  Acromegaly
  
• Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00376064 - Recruiting
  Acromegaly
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Anecortave Acetate in Patients With Open-Angle Glaucoma
  ClinicalTrials.gov Identifier: NCT00320203 - Active, not recruiting
  Open-Angle Glaucoma
  
• Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00238355 - Recruiting
  Infection; Unspecified Adult Solid Tumor, Protocol Specific
  
• Trial Comparing Ketorolac Tromethamine 0.4% and Prednisolone Acetate 1% in Reducing Post-Selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
  ClinicalTrials.gov Identifier: NCT00410267 - Recruiting
  Postoperative Complications; Inflammation; Glaucoma, Open-Angle
  
• Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
  ClinicalTrials.gov Identifier: NCT00458458 - Recruiting
  Endometriosis; Dysmenorrhea; Dyspareunia
  
• Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate
  ClinicalTrials.gov Identifier: NCT00575029 - Recruiting
  Adrenal Function
  
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
  ClinicalTrials.gov Identifier: NCT00148330 - Active, not recruiting
  Diabetic macular oedema
  
• Dose-Response of Gonadal Steroids and Bone Turnover in Men
  ClinicalTrials.gov Identifier: NCT00114114 - Recruiting
  Healthy volunteers
  
• Pilot Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00475865 - Recruiting
  Multiple Sclerosis
  
• Pharmacokinetics and Safety of Transdermal Megestrol Acetate
  ClinicalTrials.gov Identifier: NCT00163072 - Recruiting
  Cachexia
  
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00429403 - Recruiting
  Breast Cancer
  
• Study to Evaluate the Effect of Megestrol Acetate in the Weight Loss in Alzheimer Disease
  ClinicalTrials.gov Identifier: NCT00503516 - Recruiting
  Alzheimer Disease
  
• The Effect of Lapaquistat Acetate on Blood Cholesterol Levels
  ClinicalTrials.gov Identifier: NCT00532558 - Not yet recruiting
  Hypercholesterolemia
  
• Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
  ClinicalTrials.gov Identifier: NCT00331747 - Recruiting
  Multiple Sclerosis
  
• Clinical Study of Abiraterone Acetate and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00485303 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Treatment of Multiple Sclerosis with Copaxone and Albuterol
  ClinicalTrials.gov Identifier: NCT00039988 - Active, not recruiting
  Autoimmune Diseases; Multiple Sclerosis
  
• Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
  ClinicalTrials.gov Identifier: NCT00203047 - Recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00363285 - Recruiting
  Prostate Cancer
  
• A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer
  ClinicalTrials.gov Identifier: NCT00439101 - Recruiting
  Malnourished Children With Cancer
  
• Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026286 - Active, not recruiting
  stage I breast cancer; ductal breast carcinoma; menopausal symptoms; Hot Flashes; stage II breast cancer; breast cancer in situ
  
• A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00134992 - Completed
  Healthy volunteers
  
• Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00507780 - Recruiting
  Ovarian Function; Preservation of Ovarian Function
  
• Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00326625 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
  ClinicalTrials.gov Identifier: NCT00451152 - Recruiting
  Open-Angle Glaucoma
  
• A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone
  ClinicalTrials.gov Identifier: NCT00240006 - Active, not recruiting
  Multiple Sclerosis
  
• Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
  ClinicalTrials.gov Identifier: NCT00033358 - Recruiting
  Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)
  
• Efficacy and Safety of Leuprolide Acetate 3.75 Mg Depot to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00128531 - Completed
  Prostate Cancer
  
• POPART''MUS : Prevention of Post Partum Relapses with Progestin and Estradiol in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00127075 - Recruiting
  Multiple Sclerosis
  
• Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight
  ClinicalTrials.gov Identifier: NCT00507949 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Insulin Resistance and Testosterone in Women with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00123110 - Recruiting
  Metabolic Syndrome; Postmenopause
  
• Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00392938 - Recruiting
  Metastatic Cancer; Prostate Cancer
  
• Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
  ClinicalTrials.gov Identifier: NCT00364000 - Not yet recruiting
  Haemodialyzed Patients; Hyperphosphatemia
  
• hCRF for Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema Associated with Primary Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00226668 - Recruiting
  Brain Edema; Brain Tumor
  
• Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
  ClinicalTrials.gov Identifier: NCT00489840 - Recruiting
  Chronic Central Serous Chorioretinopathy
  
• Human Corticotropin-Releasing Factor (hCRF) for Patients Requiring Chronic High-Doses of Dexamethasone to Treat Edema Associated with Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00088166 - Recruiting
  Brain Edema; Brain Tumor
  
• Zinc Homeostasis and Kinetics in Children with Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00104494 - Recruiting
  Cystic Fibrosis
  
• Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00139191 - Completed
  Prostate Cancer
  
• Phase I Study of Abiraterone Acetate in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00473746 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Clinical Trial for the Prevention of Vasovagal Syncope
  ClinicalTrials.gov Identifier: NCT00118482 - Recruiting
  Syncope, Vasovagal, Neurally-Mediated
  
• A Study of Different Doses of Megestrol Acetate in Patients with AIDS Who Have Anorexia and Malnutrition
  ClinicalTrials.gov Identifier: NCT00002300 - Completed
  Anorexia; Cachexia; HIV Infections
  
• Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
  ClinicalTrials.gov Identifier: NCT00483327 - Recruiting
  Atypical Endometrial Hyperplasia; Well to Moderately Differentiated Endometrial Carcinoma
  
• A Study of Megestrol Acetate in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00002182 - Completed
  HIV Infections
  
• A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
  ClinicalTrials.gov Identifier: NCT00148265 - Recruiting
  Diabetic macular oedema
  
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
  ClinicalTrials.gov Identifier: NCT00258193 - Completed
  Irritable Bowel Syndrome
  
• Phase III Randomized Double-Blind Study Comparing Megestrol Acetate at 800 mg/day, and Placebo in AIDS Patients With Anorexia and Cachexia
  ClinicalTrials.gov Identifier: NCT00002067 - Completed
  Anorexia; Cachexia; HIV Infections
  
• A Study of Megestrol Acetate Alone or in Combination with Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
  ClinicalTrials.gov Identifier: NCT00001079 - Completed
  HIV Infections; HIV Wasting Syndrome
  
• Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening
  ClinicalTrials.gov Identifier: NCT00469781 - Recruiting
  Cystoid Macular Edema,; Retinal Thickening
  
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
  ClinicalTrials.gov Identifier: NCT00000737 - Completed
  Cachexia; HIV Infections; HIV Wasting Syndrome
  
• Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
  ClinicalTrials.gov Identifier: NCT00004650 - Completed
  Osteoporosis
  
• Manipulation of the Intratesticular Hormonal Milieu with Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
  ClinicalTrials.gov Identifier: NCT00156650 - Completed
  Contraception
  
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
  ClinicalTrials.gov Identifier: NCT00004058 - Completed
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women with Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
  ClinicalTrials.gov Identifier: NCT00004311 - Completed
  Acanthosis Nigricans; Polycystic Ovary Syndrome
  
• A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
  ClinicalTrials.gov Identifier: NCT00198523 - Completed
  Eye Infections; Postoperative Complications